Dec 9, 2019 | Articles dans les revues scientifiques, Publications
<Back to Publications Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial) Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman...
Dec 9, 2019 | Articles dans les revues scientifiques, Publications
<Back to Publications Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study Chabanon A, Seferian AM, Daron A, Péréon Y, Cances C, Vuillerot C, De Waele L, Cuisset JM, Laugel V,...
Dec 9, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy Jacqmin P, Gieschke R, Delor I, Snoeck E, Vianna E, Vuillerot C, Sanwald Ducray P.Muscle Nerve. 2018. 58(4):528-535. Presentation of a mathematical model that...
Dec 1, 2019 | Articles dans les revues scientifiques, Publications
<Back to Publications Is Going Beyond Rasch Analysis Necessary to Assess the Construct Validity of a Motor Function Scale? Guillot T, Roche S, Rippert P, Hamroun D, Iwaz J, Ecochard R, Vuillerot C; the MFM Study Group. Arch Phys Med Rehabil. 2018. 99(9),...
Recent Comments